secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0000950170-23-033261
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney closes on $25.5M purchase of 210,000 sq ft Greensboro facility for REACT manufacturing
--------------------------------------------------------------------------------

- Paid ~$25.5M cash for 210,000 sq ft facility and 22 acres in Greensboro, NC to support commercial production of REACT cell therapy.
- Eligible for up to $33.7M in tax credits (Greensboro, Guilford County, NC) and $1.9M in Duke Energy credits contingent on milestones.
- Must create at least 330 jobs by Dec 31, 2028 and invest ~$458M in property by Dec 31, 2027 to receive full incentives.
- Plans further investments through 2028 to prepare for potential commercial-scale manufacturing of REACT (Phase 3 for diabetic CKD).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017023033261/0000950170-23-033261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017023033261/prok-20230717.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-033261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer